Skip to main content

Table 2 Antipsychotics chosen by trainee in given scenario and for own care

From: Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?

Antipsychotic chosen

Physician's choice for patient

Physician's choice if they developed psychosis

Atypical

546 (94%)

530 (93%)

Typical

35 (6%)

40 (7%)

No antipsychotic

4 (0.7%)

0

Olanzapine

167 (210)

39.9% 100 (120), 26.2%

Risperidone

154 (202)

36.8% 123 (141), 32.3%

Haloperidol

28 (33)

6.7% 21 (23), 5.5%

Aripiprazole

25 (33)

6% 65 (73) 17%

Amisulpiride

17 (21)

4.1% 19 (24) 5%

Quetiapine

22 (36)

5.3% 25 (37) 6.6%

Clozapine

6 (8)

1.4% 22 (24) 5.8%

No response given regarding generic drug

202

304

Electroconvulsive therapy (ECT)

0

1 0.3%

Ziprasidone

0

4 1%

Sertindole

0

1 0.3%

  1. Percentages given are of those who responded to the question. Some respondents chose one or more antipsychotics concurrently; numbers in brackets include these additions. The table illustrates that the "atypical" class of antipsychotics were the most popular choice for patients and trainees themselves